Delivery Order SPE2DB20D7059-SPE2DB25FQNP5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) valued at $2,557.92 under a firm fixed-price contract type. The award was made on August 12, 2025, with an ultimate completion date of August 13, 2025, and utilized no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate...
- The Defense Logistics Agency awarded a $6,800.80 delivery order to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) on August 12, 2025, with a completion date of August 13, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is classified as a child contract, indicating it derives from a larger indefinite delivery...
- The Defense Logistics Agency awarded a delivery order valued at $8,958.90 to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Vaxelis vaccine syringes (0.5mL) with an ultimate completion date of August 13, 2025. This firm fixed price contract represents a non-set-aside award and will be fulfilled at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $15,207.41 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 0.5mL VAXELIS vaccine syringes, with a performance period through November 5, 2024. This Delivery Order is placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. The IDC...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order worth $3,717.72 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the delivery of VAXELIS vaccine syringes (0.5 mL) to a location in Conshohocken, Pennsylvania. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,394.80, is for the delivery of VAXELIS vaccine syringes (0.5mL) and has an ultimate completion date of March 25, 2025. The contract is a firm fixed-price agreement and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,557.92 firm fixed-price contract is for the delivery of the VAXELIS vaccine syringe 0.5 ML. The award has an ultimate completion date of February 4, 2025. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,278.96 firm fixed-price delivery order is for the VAXELIS vaccine syringe 0.5ML, with a completion date of February 11, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VAXELIS vaccine syringes. The $3,015.25 firm fixed-price contract has an ultimate completion date of October 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,278.96, is for the delivery of VAXELIS vaccine syringes (0.5 mL) and has a completion date of February 12, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. In addition to this delivery order, AmerisourceBergen holds...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQNP5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) valued at $6,394.80 under a firm fixed-price contract. The award, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a non-set-aside competitively awarded delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in Conshohocken, PA 19428. This delivery order is a child contract under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion through December 2026. This comprehensive pharmaceutical prime vendor contract enables the company to supply a wide range of pharmaceutical products and medical supplies, including vaccines and related delivery devices, to support military healthcare programs globally. The contract reflects DLA's strategic approach to pharmaceutical procurement, which includes planning for multiple regional Pharmaceutical Prime Vendor Global Program Generation V contracts to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.4k | 8/18/25 |